Moderna’s $2b mRNA factory in Melbourne is operational

Moderna’s $2 billion mRNA factory at Monash University is now finished and is already making test batches of gene-vaccines, according to media reports

Moderna’s local general manager Michael Azrak said the factory is now operational, and is producing product while waiting for final regulatory approval, the Sydney Morning Herald reported on Wednesday (archive here).

The $2 billion plant on the corner of Blackburn and Wellington roads at the Technology Precinct on Monash University’s Clayton Campus, will pump out 100 million mRNA jabs per year.

Despite the controversy around mRNA safety problems, Moderna is pushing a pipeline of gene-vaccine products for several new viruses including RSV (mRESVIA), which has never before been regarded as anything but a mild cold, as detailed here.

Other pipeline products are mRNA-1403 for norovirus, an upset stomach best prevented by washing your hands with soap and water, an “updated” Spikevax KP.2 for the covid “KP.2 sub-lineage” and Spikevax JN.1 for yet another covid variant, because the covid gene-vaccines don’t work for more than a few months, guaranteeing repeat business.

Moderna has received US$176 million in funding from BARDA to fast-track bird flu “pandemic influenza” vaccines. Some strains of avian influenza can be deadly for birds but are not a deadly risk to mammals, including people as detailed here.

The first will be mRNA-1018, in trials now for H5 and H7 strains. BARDA is the militarised wing of the US Department of Health and Human Services, whose remit includes countermeasures for biowarfare.

The $2 billion Melbourne factory was enthusiastically hailed by Australian politicians and departmental bureaucrats for creating 500 manufacturing jobs.

The Sydney Morning Herald further reported that the secret price of the factory was revealed to be $2 billion by Finance Minister Katy Gallagher in June.

Letters From Australia has made inquiries to the Senator’s office as to how much of the $2 billion was public money and will update this story with any response.

Moderna did not respond by deadline to an emailed request for comment.

Australia’s mRNA ecosystem is being propelled at the Speed of Money.

Canberra, advised during the covid panic by former Health Department secretary and CEPI chair Jane Halton, has squandered billions of dollars on boutique mRNA research while short-changing a nation that delays surgery because it can’t get IV bags.

Australia spent more than $8 billion on mRNA gene-vaccines that didn’t work and resulted in more than 100,000 reports of injury and death to the TGA’s Database of Adverse Event Notifications.

While not every reported injury can be proven to be caused by the vaccine, this is more than outweighed by the under-reporting factor which experts put at between 10 and 100.

This was made worse even worse during the covid panic because of relentless fear porn about the virus, suppression of criticism, unfounded “safe and effective vaccine” propaganda and zero public awareness of how to report a suspected injury.

Some people interviewed by Letters From Australia reported their injuries for the first time to the Covid-19 Response Inquiry this year, thinking somehow the government would “hear” them that way.

Unknown thousands of injuries are therefore not recorded in the official figures.

That’s very handy because Australia’s bureaucrats do not want to hear about injuries.

They are excited about the economic prospects of mRNA and, egged on by manufacturers, have sought to enmesh the entire academic system into promoting the new technology.

See more here substack.com

Header image: Ruby Wallau for STAT

Please Donate Below To Support Our Ongoing Work To Expose The Lies About Covid 19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Comments (1)

  • Avatar

    Tom

    |

    The saddest news ever.

    Reply

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via